News Daily News More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion Todd Neale December 05, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Conference News Watchman, Amulet LAA Closure Devices Carry Low Complication Rates Todd Neale November 04, 2016
News Industry News Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events November 02, 2016
Presentation TCT 2016 AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation Presenter: Martin B. Leon, Louis A. Cannon, David Hildick-Smith November 02, 2016
Presentation TCT 2016 WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation Presenter: Martin B. Leon, Louis A. Cannon, David R. Holmes Jr. November 02, 2016
Presentation TCT 2016 Management of Residual Leaks After LAA Closure Presenter: David R. Holmes Jr., Jacqueline Saw November 01, 2016
Presentation TCT 2016 Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure Presenter: David R. Holmes Jr., Jacqueline Saw November 01, 2016
Presentation TCT 2016 Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations Presenter: Aaron V. Kaplan, Rachel Neubrander, Tamara Syrek Jensen November 01, 2016
Presentation TCT 2016 Follow-up Evaluation After LAA Closure Presenter: David R. Holmes Jr., Jacqueline Saw, Bushra S Rana November 01, 2016
Presentation TCT 2016 Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives Presenter: Aaron V. Kaplan, Rachel Neubrander, Brian K. Whisenant November 01, 2016
Presentation TCT 2016 Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Presenter: Martin W. Bergmann, Samir R. Kapadia, Vivek Y. Reddy November 01, 2016
Presentation TCT 2016 Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See Presenter: Aaron V. Kaplan, Rachel Neubrander, Katherine Wallon November 01, 2016
Presentation TCT 2016 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White November 01, 2016
Presentation TCT 2016 Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Presenter: Martin W. Bergmann, Samir R. Kapadia, Jason H. Rogers November 01, 2016
Presentation TCT 2016 Special Tips and Tricks for LAA Closure Using the Lariat Presenter: Krzysztof Bartus, Randall J. Lee November 01, 2016
Presentation TCT 2016 Special Tips and Tricks for LAA Closure Using the Lifetech LAA Occluder Presenter: Krzysztof Bartus, Yat-Yin Lam November 01, 2016
Presentation TCT 2016 Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset Presenter: Martin W. Bergmann, Samir R. Kapadia, Brian K. Whisenant November 01, 2016
Presentation TCT 2016 Special Tips and Tricks for LAA Closure Using the Cardia LAA Occluder Presenter: Krzysztof Bartus, Josep Rodés-Cabau November 01, 2016
Presentation TCT 2016 Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient Presenter: Martin W. Bergmann, Samir R. Kapadia, Ashish Pershad November 01, 2016